Analysts Forecast 10% Growth for VIOV in the Near Future
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 24 2025
0mins
Source: NASDAQ.COM
ETF Analysis: The Vanguard S&P Small-Cap 600 Value ETF (VIOV) has an implied analyst target price of $105.34, indicating a potential upside of 10.04% from its current trading price of $95.73.
Notable Holdings: Key underlying holdings with significant upside potential include Pacira BioSciences (PCRX), Healthstream (HSTM), and Apple Hospitality REIT (APLE), each showing expected price increases of around 10% based on analyst targets.
Analyst Views on HSTM
Wall Street analysts forecast HSTM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSTM is 25.00 USD with a low forecast of 25.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 21.470
Low
25.00
Averages
25.00
High
25.00
Current: 21.470
Low
25.00
Averages
25.00
High
25.00
About HSTM
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
